Secretin

BreastfeedingPediatric
  • TRADE NAMES: ChiRhoStim; SecreFlo; Secretin-Ferring (Ferring)
  • INDICATIONS: Diagnosis of gastrinoma (Zollinger–Ellison syndrome)
  • CLASS: Hormone, polypeptide
  • HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Anticholinergics, Fesoterodine, Oxybutynin, Tiotropium, Trospium

PREGNANCY CATEGORY: C

SecreFlo is porcine-derived; ChiRhoStim is human-derived.

Our database has 6 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
GASTROINTESTINAL/HEPATIC.
LOCAL.
RESPIRATORY.


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top